ReviewEndocrine, metabolic & immune disorders drug targets2026
Research Hotspots, Trends, and Molecular Mechanisms of Diabetes and Sarcopenia: A Bibliometric and Bioinformatics Analysis.
Review in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe co-occurrence of diabetes mellitus (DM) and sarcopenia is increasingly recognized as a significant clinical challenge, yet the underlying molecular mechanisms and research landscape remain incompletely characterized.
methodsRelevant literature was retrieved from the Web of Science database, and bibliometric visualization was conducted using CiteSpace 6.2.R4 and VOSviewer 1.6.20. Genes associated with both diseases were obtained from the GeneCards and OMIM databases, and a protein-protein interaction network was constructed. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) functional enrichment analyses were performed. Bibliometric findings were cross-validated with molecular mechanisms to identify convergent evidence.
resultsThe number of publications and citation frequency in this field showed a significant upward trend. China, Japan, and the United States contributed 58.6% of research papers, with Kyoto Prefectural University of Medicine, Seoul National University, and other institutions as major contributors. Fukui Michiaki was the most productive author, and Nutrients was the primary journal. Research themes evolved from early studies on molecular pathological mechanisms to investigations of clinical phenotypes and complications, and further to nutritional interventions, exercise therapy, and population management. Bibliometric analysis identified "insulin resistance" as the second most frequent keyword (212 occurrences), correlating with bioinformatics identification of INS as the primary hub gene among 97 shared targets. Five core genes (INS, ALB, AKT1, IL6, TNF) were significantly enriched in PI3K/MAPK and inflammatory pathways, supporting bibliometric emphasis on chronic inflammation. DISCUSSION: Integration of bibliometric and bioinformatics results highlights insulin signaling, chronic inflammation, and nutritional status as common mechanisms linking DM and sarcopenia. These findings support the translational potential of lifestyle interventions (nutrition and resistance exercise) and insulin-sensitizing or anti-inflammatory therapies. Future research should focus on experimental validation and the development of combination strategies targeting the identified molecular network.
conclusionThis study constructed a comprehensive knowledge map for diabetes and sarcopenia research, systematically elucidating current research status, hot topics, and molecular mechanisms. The findings provide a scientific basis for developing joint prevention and treatment strategies and guiding future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.